I m m u n o l o g I c a l m e m o r y
The best defense The best defense is to set up multiple lines of defense against the reappearance of a pathogenic microbe. The adaptive immune system actually does this at the level of both B cells and T cells (Fig. 1) . A first encounter with antigen frequently results in the generation of longlived plasma cells that home to bone marrow niches or take up residence at mucosal sites and constitutively secrete antibody in an antigenindependent fashion to maintain serum and mucosal concentrations of antibody. The T cell correlate of this is the differentiation of effector memory cells, especially those that home to and then spend extended periods of time in barrier sites (such as the skin and mucosa). After re-entry of antigen or pathogen, as well as antigen processing and presentation, these onsite effectors can work quickly to deal with the breach even without requiring proliferation. If the infection spreads beyond the initial site of entry, circulating central memory T cells and memory B cells encounter antigen in central lymphoid organs. Here T cells will respond with rapid proliferation, making sufficient effector progeny to find pockets of infection anywhere in the body. Memory B cells, if they can capture antigen, may also interact with T cells to produce more plasmablasts that secrete antibody of higher affinity.
The best defense against many infections and the predominant participant in many of the most effective vaccines is pre-existing antibody. This is probably true for vaccines against smallpox, yellow fever and measles. Work reviewed by Pulendran and Ahmed 3 has been aimed at understanding the innate signals and the ensuing adaptive immune responses to the highly successful live attenuated vaccines (such as those mentioned above), as well as to nonliving vaccines that must be 'served up' Real or imagined memory? Naive and memory T cells are distinguished by their surface markers and by the presence of pre-formed mRNAs and permissive chromatin marks in memory cells that allow them to turn on effector functions more rapidly. Not all memory T cells defined in this way may be the result of previous encounter with foreign antigen, however. As reviewed by Sprent and Surh 1 , the circulating lymphocyte pool contains T cells of the memory phenotype even before birth. They argue that many such cells are generated by the normal process of lymphocyte homeostasis when naive cells encounter higher than normal concentrations of common γ-chain cytokines, such as interleukin 7 and interleukin 15, working in concert with weak triggering of the T cell antigen receptor (TCR) by self antigen to stimulate division. Although it flies in the face of conventional wisdom about the restricted repertoire diversity of the memory pool, this fits with results obtained by highthroughput sequencing in experiments comparing the TCR diversity of naive and memory T cell pools 2 . Contrary to the widely held belief that the memory TCR repertoire is restricted (that is, it contains large expanded clones with correspondingly low overall diversity), results have shown that a 21-year-old, healthy, cytomegalovirus-negative human subject had TCR diversity in the memory pool almost as great as that in the naive pool. Only 2-7% of memory clones seemed to be expanded. For this person, either previous antigen challenges left behind few memory cells or most memory cells were the result of slow homeostatic turnover with conversion to memory phenotype. This does not contradict the fact that as humans age and acquire certain persistent infections and T cell clonal expansion, the memory repertoire does narrow considerably.
At the population level, previous exposure to a pathogen or a form of vaccine that induces immunological memory results in less morbidity and enhanced survival. At the level of the individual organism, this means changes in the numbers and distribution of immune lymphocytes that provide more effective protection against the pathogen. At the cellular level, immunological memory depends on epigenetic changes in T lymphocytes and B lymphocytes that allow a faster effector response to pathogens. Immunological memory in B cells may also reflect genetic alterations as immunoglobulin M (IgM) antibodies switch to IgA or IgG and somatic mutations enhance antibody affinity. Beyond exposure to antigen in utero and the provision of maternal antibody, the newborn is considered immunologically naive. Realworld experience in the form of exposure to microbes, innocuous antigen and vaccination soon impinges, however, as the innocent neonate gains experience. Lymphocyte populations begin to change. Some lymphocyte clones activated in the first year of life will survive for the lifetime of the individual organism, and the circumstances that surround the first response to antigen will influence the quality of the response to subsequent encounters. This issue of Nature Immunology presents a collection of articles on the changing dynamics of the immune system as a consequence of encountering the real world.
Understand memory, design better vaccines

Michael J Bevan
Naive lymphocytes have a finite lifespan and are continually replaced by input from generative organs. In contrast, memory cells or their progeny can last a lifetime. The expanded populations of memory cells and their more widespread distribution provide protection against recurrent infection. sites, far outnumbering memory T cells in the circulation and all internal organs combined (Fig. 1) . How these regional or mucosal memory cells do their job cannot be measured in terms of their proliferative response to re-entry of the pathogen. Like pre-existing antibody, on-site effector memory cells may function by rapidly killing a neighboring infected cell or by recognizing antigen and sounding the alarm to recruit blood-borne innate effector cells without themselves undergoing rapid clonal expansion. In the case of latent infection, especially infection with herpes virus, which might recrudesce at previously infected epithelial, mucosal and neuronal sites, memory CD8 + T cells can remain on site as tissue-resident memory T cells that are separate from the recirculating memory pool 8 . This makes the primed, antigen-experienced immune system seem to be a patchwork of resident effector memory T cells grouped by previous antigen encounter. Resident memory may explain the remarkable phenomenon of 'fixed drug eruptions' that are seen as lesions at reproducible sites on the skin when an inciting drug is taken systemically.
Infections that are rapidly cleared, as well as those that result in small amounts of persistent or sporadically recurring latent antigen, leave the memory T cells functionally intact. In many cases, unraveling the role of memory T cells in acquired protection is tricky. One salient feature of protective memory highlighted by Sheridan and Lefrancois 7 is location. Many infections occur at body surfaces, such as the skin, lungs, intestinal tract and genital tract. Notably, the vast majority of effector memory T cells are present at these with an adjuvant. There is reason to expect that combinations of adjuvants that target multiple Toll-like receptors and various other intracellular alarm systems will prove to be most effective in the goal of achieving long-lived antibody and T cell immunity. Because most human vaccines approved at present depend to a large extent on humoral immunity, it is appropriate that much attention has been focused on the generation of B cell (antibody) memory and the fascinating interactions of activated B cells with antigenspecific CD4 + helper T cells. The fact that B cells and T cells specific for epitopes on the same molecular complex must meet to fully differentiate the antibody response has been known since the days of the so-called 'carrier effect' . There is an antigen bridge between B cells and T cells, even though the links in the carrier protein bridge have been broken by the B cell and displayed on the cell surface as complexes of peptide and major histocompatibility complex. As discussed by Nutt and Tarlinton O V E R V I E W far recently and has provided an understanding of the innate immune signals that serve as adjuvant targets and the diversity of homing and functional subsets of lymphocytes that the time is now ripe for newer successes against the more stubborn infections.
which binds to a mouse cytomegalovirusencoded molecule, can undergo considerable population expansion after recognizing infected cells, becoming more potent killers and cytokine producers that go on to survive in the long term in greater numbers 11 . Their activity is very much like that of T cells. Painting the skin with a variety of chemically reactive haptens or subcutaneous immunization with purified viral proteins from a range of viruses is also reported to generate specific NK cell memory 12 . The molecular basis of this recognition is unknown. It is conceivable that chemical haptenization of major histocompatibility complex molecules on target cell surfaces results in an imbalance of the inhibitory-activation signals received by a subset of NK cells, and these provide specificity and memory. Explaining how NK cells recognize matrix proteins or group antigen proteins from viruses is very difficult. Because the recognition is RAG independent, in this case it is almost necessary to invoke an undiscovered receptor system like the clonally distributed variable lymphocyte receptors used by lamprey and hagfish.
Concluding remarks
The goal of vaccination is to prevent infectious disease. Many notable, highly effective vaccines have been designed in an empirical way, with full understanding of how and why they work only arriving later. In many ways, the successes have been vaccines against the 'easy' pathogens-those that do not vary much, hide from or rapidly disable the immune system. The science of immunology has progressed so with human immunodeficiency virus and hepatitis B and C in humans, effector CD8 + T cells can gradually lose functionality as they become exhausted. As discussed by Wherry 9 , the kinetics and degree of exhaustion are closely correlated with the amount of antigen the T cells encounter, with a large amount of epitope presentation leading to rapid exhaustion. In these cases, true antigen-independent memory cell differentiation is not achieved, as the effector cells become 'addicted' to TCR triggering for survival. The exhausted T cells are marked by many surface receptors that transmit negative signals, and new treatments that block these signals have shown promise in reversing exhaustion, thereby promoting viral clearance.
Into the unknown
In addition to B lymphocytes and T lymphocytes, natural killer (NK) lymphocytes, as discussed by Paust and von Andrian 10 , have also been accredited with the ability to confer adaptive, antigen-specific memory. NK cells lack the expression of RAG recombinase proteins, which are essential for assembly of the genetic elements of B cell antigen receptors and TCRs. NK cells do have a highly complex pattern of expression of the polygenic and polymorphic Ly49 family of innate receptors (and their KIR counterparts in humans). These receptors bind major histocompatibility complex class I molecules or major histocompatibility complex class I-like molecules, which sets up a balance of inhibitory and activating signaling that is established as these cells mature. In C57BL/6 mice, NK cells that express Ly49H,
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